Migraine Excellence Hub

Excellence Forum

Leaders in the field share expert insights and institutional best practices.

Videos

Immunology
Immunology
06/25/2015
Bruce Given, MD, discusses alpha-1 antitrypsin deficiency (AATD) treatment methods, including enzyme therapy and gene therapy, and the hope that advancements in replacement therapy will improve treatments...
06/25/2015
Nasal Symptoms
Nasal Symptoms
06/18/2015
Based on the results of a double-blind comparative trial, an extract of a plant commonly known as butterbur is an effective treatment for nasal obstruction from allergic rhinitis.
06/18/2015
Nasal Symptoms
Nasal Symptoms
06/18/2015
Based on the results of a double-blind comparative trial, an extract of a plant commonly known as butterbur is an effective treatment for nasal obstruction from allergic rhinitis.
06/18/2015
Infectious Diseases
Infectious Diseases
06/11/2015
Robert M. Strauss, MD, gastroenterologist, GI Specialists of Georgia, gives an overview of the characteristics and pathology of Clostridium difficile. He explains that when the population of good...
06/11/2015
Infectious Diseases
Infectious Diseases
06/11/2015
Robert M. Strauss, MD, gastroenterologist, GI Specialists of Georgia, gives an overview of the characteristics and pathology of Clostridium difficile. He explains that when the population of good...
06/11/2015
Cardiology
Cardiology
06/04/2015
Michael H. Criqui, MD, discusses whether measuring calcium amount and density separately might better help predict if a person is at risk for developing a heart attack or stroke.
06/04/2015
Cardiology
Cardiology
06/04/2015
Michael H. Criqui, MD, discusses whether measuring calcium amount and density separately might better help predict if a person is at risk for developing a heart attack or stroke.
06/04/2015
Endocrinology
Endocrinology
05/28/2015
Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
05/28/2015
Endocrinology
Endocrinology
05/28/2015
Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
05/28/2015
conference coverage
conference coverage
05/25/2015
In this video, Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C Provide the take-home messages from their session “Agitation in Alzheimer’s Dementia: Progress for an Age-Old Problem” at our...
05/25/2015